Contexium

NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)

NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 16 Nov 2029. The purpose of NEI's Translational Research program (TRP) is the rapid and efficient translation of innovative laboratory research findings into therapeutics for use by clinicians to treat visual system diseases or disorders. The TRP will support the product development of biological, pharmaceutical…

Opportunity overview

Project name
NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)
National Institutes of Health logo
National Institutes of Health
Donor
National Institutes of Health

Key details

Opportunity start date
Opportunity end date
Project location(s)
United States

Summary

The purpose of NEI's Translational Research program (TRP) is the rapid and efficient translation of innovative laboratory research findings into...

Frequently asked questions

What is NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)?

NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 16 Nov 2029. The purpose of NEI's Translational Research program (TRP) is the rapid and efficient translation of innovative laboratory research findings into therapeutics for use by clinicians to treat visual system diseases or disorders. The TRP will support the product development of biological, pharmaceutical…

Who is funding NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)?

NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed) is funded by National Institutes of Health.

When is the deadline to apply for NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)?

The application deadline is 16 Nov 2029 00:00 (UTC).

Where will the NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed) project take place?

The project location(s) are: United States.

How can I apply for NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)?

Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.